Related Experiment Video
Updated: Dec 26, 2025

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
Published on: September 1, 2023
Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients
Annegien T Kenter1,2,3, Eveline Rentmeester1, Job van Riet4
1Department of Developmental Biology, Erasmus Medical Center Rotterdam (EMC), Oncode Institute, Rotterdam, The Netherlands.
Insights
Autosomal-dominant polycystic kidney disease (ADPKD) research advances with patient-specific induced pluripotent stem cells (iPSCs). These iPSCs model PKD1 gene function in kidney cyst formation, offering new insights into disease mechanisms.
Area of Science:
- Nephrology
- Genetics
- Stem Cell Biology
Background:
- Autosomal-dominant polycystic kidney disease (ADPKD) is the most prevalent inherited kidney disorder, frequently resulting in kidney failure.
- Mutations in the PKD1 gene account for approximately 85% of ADPKD cases, yet the molecular mechanisms of cystogenesis remain unclear.
- Induced pluripotent stem cells (iPSCs) offer a valuable platform for in vitro modeling of genetic kidney diseases.
Purpose of the Study:
- To establish and characterize ADPKD patient-specific iPSCs for studying PKD1 function in kidney development and cyst formation.
- To investigate the role of somatic mutations and DNA methylation in ADPKD pathogenesis using iPSCs derived from renal epithelial cells.
Main Methods:
- Generation of iPSCs from ADPKD patient-derived cystic renal epithelial cells and healthy controls.
- Comprehensive mutation analysis of PKD1, PKD2, and other ADPKD-associated genes in iPSCs.
- Whole-genome DNA methylation analysis to assess kidney-specific epigenetic memory and disease-associated alterations.
Main Results:
- ADPKD patient-specific iPSCs were successfully generated, harboring germline PKD1 mutations but lacking additional somatic mutations in PKD1/PKD2.
- Analysis revealed a heterogeneous mutational landscape in the original cystic cells, with limited carryover of somatic mutations into iPSCs.
- iPSCs derived from renal epithelial cells retained kidney-specific DNA methylation patterns, with distinct methylation differences observed in PKD1+/- iPSCs compared to controls.
Conclusions:
- Generated and characterized ADPKD patient-specific iPSCs provide a robust in vitro model for studying kidney development and cystogenesis.
- These iPSCs can be utilized to investigate the molecular mechanisms underlying PKD1 dysregulation in ADPKD.
- The findings highlight the potential of iPSCs in understanding inherited kidney diseases and exploring therapeutic strategies.
Abstract:
Autosomal-dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, leading to kidney failure in most patients. In approximately 85% of cases, the disease is caused by mutations in PKD1. How dysregulation of PKD1 leads to cyst formation on a molecular level is unknown. Induced pluripotent stem cells (iPSCs) are a powerful tool for in vitro modeling of genetic disorders. Here, we established ADPKD patient-specific iPSCs to study the function of PKD1 in kidney development and cyst formation in vitro. Somatic mutations are proposed to be the initiating event of cyst formation, and therefore, iPSCs were derived from cystic renal epithelial cells rather than fibroblasts. Mutation analysis of the ADPKD iPSCs revealed germline mutations in PKD1 but no additional somatic mutations in PKD1/PKD2. Although several somatic mutations in other genes implicated in ADPKD were identified in cystic renal epithelial cells, only few of these mutations were present in iPSCs, indicating a heterogeneous mutational landscape, and possibly in vitro cell selection before and during the reprogramming process. Whole-genome DNA methylation analysis indicated that iPSCs derived from renal epithelial cells maintain a kidney-specific DNA methylation memory. In addition, comparison of PKD1+/- and control iPSCs revealed differences in DNA methylation associated with the disease history. In conclusion, we generated and characterized iPSCs derived from cystic and healthy control renal epithelial cells, which can be used for in vitro modeling of kidney development in general and cystogenesis in particular.
More Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
iPS Cell Differentiation
Stem Cell Culture

